• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Optimi Health Corp (OP:OPTHF)

0.2509 +0.0030 (+1.21%)
Streaming Delayed Price Updated: 10:35 AM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,600
Open 0.2455
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2479
Today's Range 0.2454 - 0.2509
52wk Range 0.1000 - 0.2934
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Optimi Health Completes MD-MA Export for PTSD Treatment Under Australia’s Authorised Prescriber Scheme
Today 9:56 EST
(February 9, 2026) - Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of pharmaceutical psychoactive 
Via PressReach
News headline image
Optimi Health Completes First 2026 Production of MD-MA and Psilo Capsules
January 26, 2026
(January 26, 2026) - Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Health Canada-licensed manufacturer of pharmaceutical psychedelic drug 
Via PressReach

Performance

YTD
+9.1%
+9.1%
1 Month
+23.1%
+23.1%
3 Month
+4.3%
+4.3%
6 Month
+112.8%
+112.8%
1 Year
+69.0%
+69.0%

More News

Read More
News headline image
Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition ↗
September 16, 2024
Via Benzinga
News headline image
New Milestone In Psychedelics Market: Canadian Start-Up Will Export Psilocybin And MDMA To Australia ↗
June 05, 2024
Via Benzinga
News headline image
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More ↗
April 17, 2024
Via Benzinga
News headline image
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More ↗
April 17, 2024
Via Benzinga
News headline image
Optimi To Supply Psilocybin For New Zealand's Mātai Medical Research Institute ↗
April 09, 2024
Via Benzinga
News headline image
Two Top Biotechs Forge MDMA Supply Deals For Clinical Research ↗
March 26, 2024
Via Benzinga
News headline image
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review ↗
March 16, 2024
Via Benzinga
News headline image
Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More ↗
March 01, 2024
Via Benzinga
News headline image
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More ↗
January 26, 2024
Via Benzinga
News headline image
Psychedelics Headlines: Magic Mushrooms For Sexual Wellbeing, The DEA's Stance, The Therapist's Role & More ↗
January 08, 2024
Via Benzinga
News headline image
Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More ↗
September 11, 2023
Via Benzinga
Topics Artificial Intelligence
News headline image
Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing ↗
September 08, 2023
Via Benzinga
News headline image
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More ↗
August 14, 2023
Via Benzinga
News headline image
Natural Psilocybin Companies Diversify: Latest By Optimi, Red Light Holland And A European Player ↗
August 01, 2023
Via Benzinga
News headline image
MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University ↗
June 20, 2023
Via Benzinga
News headline image
Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More ↗
May 23, 2023
Via Benzinga
News headline image
The Psychedelic Mushrooms Market; Between Legitimate Harvesting And Illegal Retail Sales ↗
May 17, 2023
Via Benzinga
News headline image
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More ↗
May 15, 2023
Via Benzinga
News headline image
Optimi Health Boosts Psilocybin Production With New Health Canada License And Supply Deal ↗
May 11, 2023
Via Benzinga
News headline image
What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry ↗
April 03, 2023
Via Benzinga
News headline image
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More ↗
March 07, 2023
Via Benzinga
News headline image
Australia Receives First Batch Of Clinical-Grade Psilocybin From Mindset Pharma And PharmAla ↗
March 06, 2023
Via Benzinga
News headline image
Latest Psychedelics Deals: Optimi Supplies Australia, Awakn Partners Licensing In California ↗
March 02, 2023
Via Benzinga

Frequently Asked Questions

Is Optimi Health Corp publicly traded?
Yes, Optimi Health Corp is publicly traded.
What exchange does Optimi Health Corp trade on?
Optimi Health Corp trades on the OTC Traded
What is the ticker symbol for Optimi Health Corp?
The ticker symbol for Optimi Health Corp is OPTHF on the OTC Traded
What is the current price of Optimi Health Corp?
The current price of Optimi Health Corp is 0.2509
When was Optimi Health Corp last traded?
The last trade of Optimi Health Corp was at 02/09/26 10:35 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap